Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Clinical trial NCT00109005 · COMPLETED
Trial details
- NCT number
- NCT00109005
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2009-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.